Literature DB >> 15750045

Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.

Mie Mochizuki1, Yukio Ishii, Ken Itoh, Takashi Iizuka, Yuko Morishima, Toru Kimura, Takumi Kiwamoto, Yosuke Matsuno, Ahamed E Hegab, Akihiro Nomura, Tohru Sakamoto, Koji Uchida, Masayuki Yamamoto, Kiyohisa Sekizawa.   

Abstract

RATIONALE: Acute lung injury (ALI) is a disease process that is characterized by diffuse inflammation in the lung parenchyma. Recent studies demonstrated that cyclooxygenase-2 (COX-2) induced at the late phase of inflammation aids in the resolution of inflammation by generating 15-deoxy-delta(12,14)-prostaglandin J2 (15d-PGJ2). Transcription factor Nrf2 is activated by electrophiles and exerts antiinflammatory effects by inducing the gene expression of antioxidant and detoxification enzymes.
OBJECTIVES: Because 15d-PGJ2 is an endogenous electrophile, we hypothesized that it protects against ALI by activating Nrf2.
METHODS: To test this hypothesis, we generated a reversible ALI model by intratracheal injection of carrageenin, an inducer of acute inflammation, whose stimulation has been known to induce COX-2. MAIN
RESULTS: We found that ALI induced by carrageenin was markedly exacerbated in Nrf2-knockout mice, compared with wild-type mice. Analysis of bronchoalveolar lavage fluids also revealed that the magnitude and the duration of acute inflammation, indicated by albumin concentration and the number of neutrophils, were significantly enhanced in Nrf2-knockout mice. Treatment of wild-type mice with NS-398, a selective COX-2 inhibitor, significantly exacerbated ALI to the level of Nrf2-knockout mice. In the lungs of NS-398-treated wild-type mice, both the accumulation of 15d-PGJ2 and the induction of Nrf2 target antioxidant genes were significantly attenuated. Exogenous administration of 15d-PGJ2 reversed the exacerbating effects of NS-398 with the induction of antioxidant genes.
CONCLUSIONS: These results demonstrated in vivo that 15d-PGJ2 plays a protective role against ALI by exploiting the Nrf2-mediated transcriptional pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750045     DOI: 10.1164/rccm.200406-755OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  42 in total

1.  Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.

Authors:  Akshaya K Meher; Poonam R Sharma; Vitor A Lira; Masayuki Yamamoto; Thomas W Kensler; Zhen Yan; Norbert Leitinger
Journal:  Free Radic Biol Med       Date:  2012-02-24       Impact factor: 7.376

2.  Nrf2 is essential for the expression of lipocalin-prostaglandin D synthase induced by prostaglandin D2.

Authors:  Kyun Ha Kim; Ruxana T Sadikot; Lei Xiao; John W Christman; Michael L Freeman; Jefferson Y Chan; Yu-Kyoung Oh; Timothy S Blackwell; Myungsoo Joo
Journal:  Free Radic Biol Med       Date:  2013-09-09       Impact factor: 7.376

Review 3.  Endogenous lipid mediators in the resolution of airway inflammation.

Authors:  O Haworth; B D Levy
Journal:  Eur Respir J       Date:  2007-11       Impact factor: 16.671

Review 4.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

5.  ent-kaur-16-en-19-oic Acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2.

Authors:  Ji Hyo Lyu; Geum San Lee; Kyun Ha Kim; Hyung-Woo Kim; Su-In Cho; Seung-Il Jeong; Hong-Jun Kim; Young-Seung Ju; Ho-Kyoung Kim; Ruxana T Sadikot; John W Christman; Sei-Ryang Oh; Hyeong-Kyu Lee; Kyung-Seop Ahn; Myungsoo Joo
Journal:  J Ethnopharmacol       Date:  2011-08-23       Impact factor: 4.360

6.  Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids.

Authors:  Alison L Groeger; Chiara Cipollina; Marsha P Cole; Steven R Woodcock; Gustavo Bonacci; Tanja K Rudolph; Volker Rudolph; Bruce A Freeman; Francisco J Schopfer
Journal:  Nat Chem Biol       Date:  2010-05-02       Impact factor: 15.040

7.  Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.

Authors:  Jai Prakash; Ruchi Bansal; Eduard Post; Alie de Jager-Krikken; Marjolijn N Lub-de Hooge; Klaas Poelstra
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats.

Authors:  Ana Fernandez-Bustamante; Jelena Klawitter; Paul Wilson; Nancy D Elkins; Amanda Agazio; Takahiro Shibata; Koji Uchida; Uwe Christians; John E Repine
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

9.  NF-kappaB dependent and independent mechanisms of quartz-induced proinflammatory activation of lung epithelial cells.

Authors:  Damien van Berlo; Ad M Knaapen; Frederik-Jan van Schooten; Roel Pf Schins; Catrin Albrecht
Journal:  Part Fibre Toxicol       Date:  2010-05-21       Impact factor: 9.400

10.  Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo.

Authors:  Tomohiro Kawamura; Nobunao Wakabayashi; Norihisa Shigemura; Chien-Sheng Huang; Kosuke Masutani; Yugo Tanaka; Kentaro Noda; Ximei Peng; Toru Takahashi; Timothy R Billiar; Meinoshin Okumura; Yoshiya Toyoda; Thomas W Kensler; Atsunori Nakao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.